Novel, safe and
efficacious hRPP therapy
First in class
Human Recombinant Protein Platform targeting specific key disease areas
Novel, safe and efficacious hRPP therapy
First in class Human Recombinant Protein Platform targeting specific key disease areas
Longevity / Anti-ageing
Anti-inflammatory
Anti-viral
About Us
Bio Immunitas LLC is an EIS-qualified pharmaceutical company.
We have developed a novel, safe and efficacious human Recombinant Protein Platform (hRPP) therapy that has a unique multi-level mechanism of action with several key indications of use:
- First in class therapy - immunotherapy and senolytic (clearing senescent cells). Anti-ageing treatment.
- Broad spectrum anti-inflammatory
- Anti-SAR-CoV-2 therapy – hospitalised patients
Team
Professor Syed Haq MBBS BSc PhD DIC MRCP
CMO of several biopharmaceutical companies developing platforms in inflammatory diseases and neurodegenerative diseases.
Dr Masud Haq MBBS BSc MD FRCP
A Consultant Physician in Diabetes, Endocrinology and General Medicine, Dr Haq is a key opinion leader for several pharmaceutical companies.
Alexandra Haq, BSc (Hons) PGD INP
Alex studied both Nursing and Law and is a published author in the realm of aesthetic medicine. Editorial Board member of the Journal of Aesthetic Nursing.
Timothy John Gamble BSc MSc
Head of consulting at The Economist Intelligence Unit, following 15 years at Pfizer Inc. Highly experienced in finance, and biopharmaceutical sectors.
Team
Professor Syed Haq MBBS BSc PhD DIC MRCP
CMO of several biopharmaceutical companies developing platforms in inflammatory diseases and neurodegenerative diseases.
Dr Masud Haq MBBS BSc MD FRCP
A Consultant Physician in Diabetes, Endocrinology and General Medicine, Dr Haq is a key opinion leader for several pharmaceutical companies.
Saloni Jackson EXEC MBA BA (Hons)
A strategic b2b and b2c senior business professional of 22+ years, working with stakeholders on transformational projects and change management.
Alexandra Haq, BSc (Hons) PGD INP
Alex studied both Nursing and Law and is a published author in the realm of aesthetic medicine. Editorial Board member of the Journal of Aesthetic Nursing.
Timothy John Gamble BSc MSc
Head of consulting at The Economist Intelligence Unit, following 15 years at Pfizer Inc. Highly experienced in finance, and biopharmaceutical sectors.